AACR Cancer Progress Report

In the United States, 40 percent of all cancers are associated with modifiable risk factors.

Research-driven advances in identifying genetic mutations that fuel tumor growth have set the stage for a new era of precision medicine.

Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment.